SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-004218
Filing Date
2021-02-18
Accepted
2021-02-18 10:08:30
Documents
6
Period of Report
2021-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43876
2 ex10-1.htm EX-10.1 227389
3 ex10-2.htm EX-10.2 163937
4 ex10-3.htm EX-10.3 88021
5 ex99-1.htm EX-99.1 11166
6 ex99-1_001.jpg GRAPHIC 3641
  Complete submission text file 0001493152-21-004218.txt   540846
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 21648045
SIC: 2834 Pharmaceutical Preparations